These data were consistent with the notion that SN-401 and SWELL1-active congeners are functioning to stabilize SWELL1-LRRC8 assembly and signaling under glucolipotoxic conditions associated with T2D and metabolic syndrome. This evidence concerns the gene LRRC8A and metabolic syndrome.